Beren Therapeutics
PrivateLast Round
Early Funding
Jun 10, 2026
Total Funding Raised
$300M
Company Overview
Beren Therapeutics is a biotechnology company focused on developing innovative and effective therapies to ensure accessibility for all patients, addressing health-related issues with a preventive approach.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beren Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Beren Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 10, 2026 | ||||
| Strategic | May 23, 2023 |
Beren Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Narya Capital | Early Funding |
| Founders Fund | Early Funding |
| JIC Venture Growth Investments | Early Funding |
| Wellington Partners | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 10, 2026
$135M raised with participation from Founders Fund.
Beren Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Beren Therapeutics's valuation, stock price, and market status.
